| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.28B | 44.55B | 39.09B | 38.68B | 37.89B | 35.67B |
| Gross Profit | 7.28B | 7.65B | 7.24B | 7.08B | 6.61B | 6.60B |
| EBITDA | 3.46B | 3.32B | 3.65B | 3.40B | 3.06B | 3.26B |
| Net Income | 898.00M | 950.00M | 914.00M | 800.00M | 1.57B | 49.00M |
Balance Sheet | ||||||
| Total Assets | 84.65B | 93.96B | 85.61B | 83.30B | 82.04B | 81.60B |
| Cash, Cash Equivalents and Short-Term Investments | 6.35B | 6.41B | 5.90B | 5.37B | 5.00B | 5.08B |
| Total Debt | 26.53B | 31.63B | 26.82B | 25.25B | 24.94B | 25.03B |
| Total Liabilities | 49.82B | 57.73B | 50.37B | 49.21B | 48.68B | 49.79B |
| Stockholders Equity | 34.79B | 36.20B | 35.21B | 34.06B | 33.34B | 31.81B |
Cash Flow | ||||||
| Free Cash Flow | 464.00M | -616.00M | -835.00M | 755.00M | -59.00M | 2.42B |
| Operating Cash Flow | 703.00M | 907.00M | 2.11B | 3.55B | 1.11B | 2.99B |
| Investing Cash Flow | -272.50M | -4.63B | -2.77B | -2.70B | -682.00M | -654.00M |
| Financing Cash Flow | -392.50M | 4.29B | 1.07B | -509.00M | -579.00M | -3.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥174.90B | 11.62 | 10.24% | 2.43% | 7.59% | 9.69% | |
77 Outperform | ¥141.46B | 21.73 | ― | 1.79% | 7.03% | 26.11% | |
69 Neutral | ¥767.85B | 16.33 | 27.58% | 0.99% | 8.43% | 225.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥1.59T | 20.78 | 3.37% | 1.85% | 0.85% | 8.37% | |
58 Neutral | ¥12.52B | 14.23 | ― | 4.80% | 13.99% | 3.21% | |
54 Neutral | ¥108.17B | 233.67 | 2.80% | 3.38% | -4.52% | -91.68% |